A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The study was designed to analyze the efficacy and safety of Paxlovid for the treatment of COVID-19.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Healthy Volunteers: f
View:
• Participants who have a positive SARS-CoV-2 test result;
• Participants who have one or more mild or moderate COVID-19 symptoms.
Locations
Other Locations
China
Huashan Hospital Affiliated to Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Feng Sun, MD
aaronsf1125@126.com
+86 02152889999
Time Frame
Start Date: 2022-03-21
Estimated Completion Date: 2027-03-30
Participants
Target number of participants: 2000
Treatments
Paxlovid
Patients with COVID-19 who visit Huashan Hospital,Fudan University from 2022 to 2027 and receive Paxlovid therapy
Routine therapy
Patients with COVID-19 who visit Huashan Hospital,Fudan University from 2022 to 2027 and receive routine therapy without paxlovid
Related Therapeutic Areas
Sponsors
Leads: Huashan Hospital